Abstract

56P FOXM1D in T cells promotes the transcription of PD-1 by interacting with HCFC1 and regulating the killing of renal cancer cells

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Polysaccharide nano-vesicular multidrug carriers for synergistic killing of cancer cells.
Nagaraj Balasubramanian ... Manickam Jayakannan
Nanoscale | VOL. 6
Nagaraj Balasubramanian, et. al.Nagaraj Balasubramanian ... Manickam Jayakannan
01 Jan 2014
Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Shailaja Kesaraju ... Kasirajan Ayyanathan
PLoS ONE | VOL. 7
Shailaja Kesaraju, et. al.Shailaja Kesaraju ... Kasirajan Ayyanathan
17 Jul 2012
CD6 is a target for cancer immunotherapy.
Thomas M Lanigan ... Nora G Singer
JCI insight | VOL. 6
Thomas M Lanigan, et. al.Thomas M Lanigan ... Nora G Singer
08 Mar 2021
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
B.J Monk ... U.A Matulonis
Annals of Oncology | VOL. 28
B.J Monk, et. al.B.J Monk ... U.A Matulonis
01 Mar 2017
View more papers

More From: Immuno-Oncology and Technology

Paper Title
Journal
Date
Author
Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy – a retrospective and biomarker study
Fernanda Costa Svedman ... Suzanne Egyhazi Brage
Immuno-Oncology and Technology | VOL. -
Fernanda Costa Svedman, et. al.Fernanda Costa Svedman ... Suzanne Egyhazi Brage
01 May 2024
Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
Caroline Dive ... Kirellos S Abbas
Immuno-Oncology and Technology | VOL. 22
Caroline Dive, et. al.Caroline Dive ... Kirellos S Abbas
18 Mar 2024
Table of Contents
-
Immuno-Oncology and Technology | VOL. 21
--
01 Mar 2024
Editorial Board
-
Immuno-Oncology and Technology | VOL. 21
--
01 Mar 2024
View more papers